학술논문
Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials
Document Type
Article
Author
Source
In: Annals of Hematology . (Annals of Hematology, September 2021, 100(9):2387-2398)
Subject
Language
English
ISSN
14320584
09395555
09395555